Keith Wayne Ward, Chief Development Officer at REATA PHARMACEUTICALS INC (RETA), sold 6,900 shares at $76.17 ($530K) on 2019-01-31, disclosed to the SEC on 2019-02-01.
Open-market sale of $530k RETA by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $76.17 | 1,400 | $107K | 20.1% |
| 2 | $76.97 | 2,750 | $212K | 39.9% |
| 3 | $76.97 | 2,750 | $212K | 39.9% |
| Total | $76.81 avg | 6,900 | $530K | 100% |
| Filing → |
| RETA | SELL | 2018-11-08 | $636K | — | Filing → |
| RETA | SELL | 2018-11-01 | $283K | — | Filing → |
| RETA | SELL | 2018-10-24 | $813K | — | Filing → |